Bockenstedt L, Wooten R, Baumgarth N
Curr Issues Mol Biol. 2020; 42:145-190.
PMID: 33289684
PMC: 10842262.
DOI: 10.21775/cimb.042.145.
Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L
Elife. 2020; 9.
PMID: 32613944
PMC: 7438111.
DOI: 10.7554/eLife.55319.
Liang L, Wang J, Schorter L, Nguyen Trong T, Fell S, Ulrich S
Parasit Vectors. 2020; 13(1):191.
PMID: 32312278
PMC: 7171858.
DOI: 10.1186/s13071-020-04060-y.
Lin Y, Yu Y, Marcinkiewicz A, Lederman P, Hart T, Zhang F
ACS Infect Dis. 2020; 6(3):503-514.
PMID: 31961652
PMC: 7241291.
DOI: 10.1021/acsinfecdis.9b00425.
Bamm V, Ko J, Mainprize I, Sanderson V, Wills M
Pathogens. 2020; 8(4).
PMID: 31888245
PMC: 6963551.
DOI: 10.3390/pathogens8040299.
The role of Mannose Binding Lectin in the immune response against Borrelia burgdorferi sensu lato.
Coumou J, Wagemakers A, Narasimhan S, Schuijt T, Ersoz J, Oei A
Sci Rep. 2019; 9(1):1431.
PMID: 30723261
PMC: 6363739.
DOI: 10.1038/s41598-018-37922-8.
Citrate Anticoagulant Improves the Sensitivity of Borreliella (Borrelia) burgdorferi Plasma Culture.
Marques A, Yang X, Smith A, Zhuang X, Turk S, Williams C
J Clin Microbiol. 2017; 55(11):3297-3299.
PMID: 28878005
PMC: 5654915.
DOI: 10.1128/JCM.01046-17.
Borrelia burgdorferi infection induces lipid mediator production during Lyme arthritis.
Brown C, Dennis E
Biochimie. 2017; 141:86-90.
PMID: 28630010
PMC: 5610093.
DOI: 10.1016/j.biochi.2017.06.010.
T Cells Exacerbate Lyme Borreliosis in TLR2-Deficient Mice.
Lasky C, Pratt C, Hilliard K, Jones J, Brown C
Front Immunol. 2016; 7:468.
PMID: 27857714
PMC: 5093308.
DOI: 10.3389/fimmu.2016.00468.
Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.
Lasky C, Jamison K, Sidelinger D, Pratt C, Zhang G, Brown C
Infect Immun. 2015; 83(7):2882-8.
PMID: 25939508
PMC: 4468557.
DOI: 10.1128/IAI.00533-15.
Macrophage Polarization during Murine Lyme Borreliosis.
Lasky C, Olson R, Brown C
Infect Immun. 2015; 83(7):2627-35.
PMID: 25870230
PMC: 4468556.
DOI: 10.1128/IAI.00369-15.
BB0238, a presumed tetratricopeptide repeat-containing protein, is required during Borrelia burgdorferi mammalian infection.
Groshong A, Fortune D, Moore B, Spencer H, Skinner R, Bellamy W
Infect Immun. 2014; 82(10):4292-306.
PMID: 25069985
PMC: 4187884.
DOI: 10.1128/IAI.01977-14.
Forward genetic approaches for elucidation of novel regulators of Lyme arthritis severity.
Bramwell K, Teuscher C, Weis J
Front Cell Infect Microbiol. 2014; 4:76.
PMID: 24926442
PMC: 4046100.
DOI: 10.3389/fcimb.2014.00076.
The role of eicosanoids in experimental Lyme arthritis.
Pratt C, Brown C
Front Cell Infect Microbiol. 2014; 4:69.
PMID: 24904842
PMC: 4036060.
DOI: 10.3389/fcimb.2014.00069.
Comparative population genomics of the Borrelia burgdorferi species complex reveals high degree of genetic isolation among species and underscores benefits and constraints to studying intra-specific epidemiological processes.
Jacquot M, Gonnet M, Ferquel E, Abrial D, Claude A, Gasqui P
PLoS One. 2014; 9(4):e94384.
PMID: 24721934
PMC: 3993988.
DOI: 10.1371/journal.pone.0094384.
Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection.
Hastey C, Elsner R, Barthold S, Baumgarth N
J Immunol. 2012; 188(11):5612-22.
PMID: 22547698
PMC: 3358496.
DOI: 10.4049/jimmunol.1103735.
Hamster and murine models of severe destructive Lyme arthritis.
Munson E, Nardelli D, Du Chateau B, Callister S, Schell R
Clin Dev Immunol. 2012; 2012:504215.
PMID: 22461836
PMC: 3296304.
DOI: 10.1155/2012/504215.
Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity.
Hyde J, Weening E, Chang M, Trzeciakowski J, Hook M, Cirillo J
Mol Microbiol. 2011; 82(1):99-113.
PMID: 21854463
PMC: 3183165.
DOI: 10.1111/j.1365-2958.2011.07801.x.
5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis.
Blaho V, Zhang Y, Hughes-Hanks J, Brown C
J Immunol. 2011; 186(5):3076-84.
PMID: 21270404
PMC: 3346295.
DOI: 10.4049/jimmunol.1003473.
A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity.
Yang X, Coleman A, Anguita J, Pal U
PLoS Pathog. 2009; 5(3):e1000326.
PMID: 19266024
PMC: 2644780.
DOI: 10.1371/journal.ppat.1000326.